Literature DB >> 19357143

Distinct clinical phenotypes of airways disease defined by cluster analysis.

M Weatherall1, J Travers, P M Shirtcliffe, S E Marsh, M V Williams, M R Nowitz, S Aldington, R Beasley.   

Abstract

Airways disease is currently classified using diagnostic labels such as asthma, chronic bronchitis and emphysema. The current definitions of these classifications may not reflect the phenotypes of airways disease in the community, which may have differing disease processes, clinical features or responses to treatment. The aim of the present study was to use cluster analysis to explore clinical phenotypes in a community population with airways disease. A random population sample of 25-75-yr-old adults underwent detailed investigation, including a clinical questionnaire, pulmonary function tests, nitric oxide measurements, blood tests and chest computed tomography. Cluster analysis was performed on the subgroup with current respiratory symptoms or obstructive spirometric results. Subjects with a complete dataset (n = 175) were included in the cluster analysis. Five clusters were identified with the following characteristics: cluster 1: severe and markedly variable airflow obstruction with features of atopic asthma, chronic bronchitis and emphysema; cluster 2: features of emphysema alone; cluster 3: atopic asthma with eosinophilic airways inflammation; cluster 4: mild airflow obstruction without other dominant phenotypic features; and cluster 5: chronic bronchitis in nonsmokers. Five distinct clinical phenotypes of airflow obstruction were identified. If confirmed in other populations, these findings may form the basis of a modified taxonomy for the disorders of airways obstruction.

Entities:  

Mesh:

Year:  2009        PMID: 19357143     DOI: 10.1183/09031936.00174408

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  65 in total

1.  Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program.

Authors:  Anne M Fitzpatrick; W Gerald Teague; Deborah A Meyers; Stephen P Peters; Xingnan Li; Huashi Li; Sally E Wenzel; Shean Aujla; Mario Castro; Leonard B Bacharier; Benjamin M Gaston; Eugene R Bleecker; Wendy C Moore
Journal:  J Allergy Clin Immunol       Date:  2010-12-31       Impact factor: 10.793

2.  The natural history of asthma phenotypes identified by cluster analysis. Looking for chutes and ladders.

Authors:  Wendy C Moore
Journal:  Am J Respir Crit Care Med       Date:  2013-09-01       Impact factor: 21.405

3.  Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Authors:  MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

4.  Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.

Authors:  Inmaculada Arostegui; Cristobal Esteban; Susana García-Gutierrez; Marisa Bare; Nerea Fernández-de-Larrea; Eduardo Briones; José M Quintana
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

5.  Quantitative Imaging Markers of Lung Function in a Smoking Population Distinguish COPD Subgroups with Differential Lung Cancer Risk.

Authors:  Christine M Lusk; Angela S Wenzlaff; Donovan Watza; Jessica C Sieren; Natasha Robinette; Garrett Walworth; Michael Petrich; Christine Neslund-Dudas; Michael J Flynn; Thomas Song; David Spizarny; Michael J Simoff; Ayman O Soubani; Shirish Gadgeel; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-14       Impact factor: 4.254

Review 6.  Epidemiology of the origins of airflow limitation in asthma.

Authors:  Stefano Guerra; Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2009-12

Review 7.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

8.  The diversity of young adult wheeze: a cluster analysis in a longitudinal birth cohort.

Authors:  R J Kurukulaaratchy; H Zhang; A Raza; V Patil; W Karmaus; S Ewart; S H Arshad
Journal:  Clin Exp Allergy       Date:  2014       Impact factor: 5.018

9.  Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation.

Authors:  Michael H Cho; George R Washko; Thomas J Hoffmann; Gerard J Criner; Eric A Hoffman; Fernando J Martinez; Nan Laird; John J Reilly; Edwin K Silverman
Journal:  Respir Res       Date:  2010-03-16

Review 10.  Integrative systems biology approaches in asthma pharmacogenomics.

Authors:  Amber Dahlin; Kelan G Tantisira
Journal:  Pharmacogenomics       Date:  2012-09       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.